查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386150

伴侣动物疫苗市场报告：2030 年趋势、预测与竞争分析

Companion Animal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

伴侣动物疫苗趋势和预测

预计到 2030 年，全球伴侣动物疫苗市场将达到 48 亿美元，2024 年至 2030 年年复合成长率为 6.3%。该市场的主要驱动因素是人们对宠物疫苗接种重要性的认识不断提高、通用感染疾病病例不断增加以及世界各地对养宠物的兴趣日益浓厚。全球伴侣动物疫苗市场前景广阔，医院和诊所市场以及研究机构市场充满机会。

伴侣动物疫苗市场洞察

Lucintel 预测，由于饲主越来越意识到接种疫苗以保护宠物免受严重疾病的重要性，犬科动物仍将是最大的细分市场。

在这个市场中，医院和诊所预计将在预测期内实现最高成长。

由于宠物拥有量较高以及该地区人口对宠物疫苗接种重要性的认识不断增强，北美可能仍然是最大的地区。

市场规模/估计：以金额估计伴侣动物疫苗的市场规模（十亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按产品类型、物种类型、最终用途和地区分類的伴侣动物疫苗市场规模（金额（十亿美元））。

区域分析：北美、欧洲、亚太地区和世界其他地区、中东和非洲伴侣动物疫苗市场细分。

成长机会：伴侣动物疫苗市场成长机会依产品类型、动物种类、最终用途及地区进行分析。

策略分析：这包括併购、新产品开发以及伴侣动物疫苗市场的竞争形势。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球伴侣动物疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球伴侣动物疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球伴侣动物疫苗市场
    • 减毒变态
    • 组合型
    • 失活
    • 亚基
    • 类毒素
    • DNA
    • 重组
  • 按物种类型分類的全球伴侣动物疫苗市场
    • 犬科动物
    • 鸟类
    • 猫科动物
    • 马
  • 全球伴侣动物疫苗市场（依最终用途）
    • 医院和诊所
    • 研究机构
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球伴侣动物疫苗市场区域分布
  • 北美伴侣动物疫苗市场
  • 欧洲伴侣动物疫苗市场
  • 亚太地区伴侣动物疫苗市场
  • 其他地区伴侣动物疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球伴侣动物疫苗市场成长机会
    • 按物种类型分類的全球伴侣动物疫苗市场成长机会
    • 全球伴侣动物疫苗市场成长机会（依最终用途）
    • 全球伴侣动物疫苗市场成长机会（按地区）
  • 全球伴侣动物疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球伴侣动物疫苗市场的产能
    • 全球伴侣动物疫苗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Elanco
  • Boehringer Ingelheim International
  • Intervet
  • Zoetis Services
  • Bioveta
  • Sanofi
  • Bayer
  • Heska
  • Virbac
  • Hester Biosciences
简介目录

Companion Animal Vaccine Trends and Forecast

The future of the global companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets. The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

A more than 150-page report is developed to help in your business decisions.

Companion Animal Vaccine by Segment

The study includes a forecast for the global companion animal vaccine by product type, species type, end use, and region.

Companion Animal Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live
  • Conjugate
  • Inactivated
  • Subunit
  • Toxoid
  • DNA
  • Recombinant

Companion Animal Vaccine Market by Species Type [Shipment Analysis by Value from 2018 to 2030]:

  • Canine
  • Avian
  • Feline
  • Equine

Companion Animal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Institutes
  • Others

Companion Animal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Companion Animal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies companion animal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the companion animal vaccine companies profiled in this report include-

  • Elanco
  • Boehringer Ingelheim International
  • Intervet
  • Zoetis Services
  • Bioveta
  • Sanofi
  • Bayer
  • Heska
  • Virbac
  • Hester Biosciences

Companion Animal Vaccine Market Insights

Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Within this market, hospital & clinic is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Features of the Global Companion Animal Vaccine Market

Market Size Estimates: Companion animal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Companion animal vaccine market size by product type, species type, end use, and region in terms of value ($B).

Regional Analysis: Companion animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, species types, end uses, and regions for the companion animal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the companion animal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the companion animal vaccine market size?

Answer: The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030.

Q.2 What is the growth forecast for companion animal vaccine market?

Answer: The global companion animal vaccine market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the companion animal vaccine market?

Answer: The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

Q4. What are the major segments for companion animal vaccine market?

Answer: The future of the companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets.

Q5. Who are the key companion animal vaccine market companies?

Answer: Some of the key companion animal vaccine companies are as follows:

  • Elanco
  • Boehringer Ingelheim International
  • Intervet
  • Zoetis Services
  • Bioveta
  • Sanofi
  • Bayer
  • Heska
  • Virbac
  • Hester Biosciences

Q6. Which companion animal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Q7. In companion animal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the companion animal vaccine market by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), end use (hospitals & clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Companion Animal Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Companion Animal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Companion Animal Vaccine Market by Product Type
    • 3.3.1: Attenuated Live
    • 3.3.2: Conjugate
    • 3.3.3: Inactivated
    • 3.3.4: Subunit
    • 3.3.5: Toxoid
    • 3.3.6: DNA
    • 3.3.7: Recombinant
  • 3.4: Global Companion Animal Vaccine Market by Species Type
    • 3.4.1: Canine
    • 3.4.2: Avian
    • 3.4.3: Feline
    • 3.4.4: Equine
  • 3.5: Global Companion Animal Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Research Institutes
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Companion Animal Vaccine Market by Region
  • 4.2: North American Companion Animal Vaccine Market
    • 4.2.1: North American Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.2.2: North American Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
  • 4.3: European Companion Animal Vaccine Market
    • 4.3.1: European Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.3.2: European Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
  • 4.4: APAC Companion Animal Vaccine Market
    • 4.4.1: APAC Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.4.2: APAC Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
  • 4.5: ROW Companion Animal Vaccine Market
    • 4.5.1: ROW Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.5.2: ROW Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Companion Animal Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Companion Animal Vaccine Market by Species Type
    • 6.1.3: Growth Opportunities for the Global Companion Animal Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Companion Animal Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Companion Animal Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Companion Animal Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Companion Animal Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Elanco
  • 7.2: Boehringer Ingelheim International
  • 7.3: Intervet
  • 7.4: Zoetis Services
  • 7.5: Bioveta
  • 7.6: Sanofi
  • 7.7: Bayer
  • 7.8: Heska
  • 7.9: Virbac
  • 7.10: Hester Biosciences